Limin Liao

Dr. Limin Liao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YZYongheng Zhou
Yongheng Zhou
ZHZitian He
Zitian He
TXTianyu Xiang
Tianyu Xiang
XCXiaoyan Cao
Xiaoyan Cao
HCHuiling Cong
Huiling Cong
LLLimin Liao
Limin Liao
Background: The effectiveness and safety of the instillation of botulinum toxin A (BTX-A) remain subjects of controversy. The meta-analysis was performed to assess the efficacy and safety of a novel intravesical instillation of BTX-A for managing overactive bladder (OAB) or interstitial cystitis/bladder pain syndrome (IC/BPS).Method: The randomized controlled trials were retrieved from PubMed, EMBASE, and the Cochrane Library databases up to 29 January 2024. The studies included in the analysis focused on the intravesical instillation of BTX-A in patients with OAB or IC/BPS. The data extraction was independently conducted by two reviewers. The random effects model was utilized for the assessment in order to compute the overall effect sizes. The heterogeneity tests and subgroup analyses were conducted.Results: The meta-analysis and subgroup analysis did not reveal any statistically significant differences. However, the results of the meta-analysis indicated that intravesical instillation of BTX-A could reduce episodes of urgency urinary incontinence (UUI) (overall weighted mean difference [WMD] = −0.85; 95% confidence interval [CI]: -2.99 to 1.29). In subgroup analysis, an increase in void volume (VV) at 4 weeks of follow-up (WMD = −31.99; 95% CI: -70.53 to 6.54) was observed compared to that at 12 weeks (WMD = −1.73; 95% CI: -16.98 to 13.53). In contrast to the groups receiving more than 200 units of BTX-A, patients in the group receiving 200 units or fewer of BTX-A (WMD = −16.89; 95% CI: -41.14 to 7.35) exhibited a significantly greater increase in VV.Conslusion: The intravesical instillation of BTX-A appears to be a viable administration route that may reduce UUI and VV to some extent. In terms of safety, intravesical instillation of BTX-A demonstrated a reduced risk of UTI and post-void residual compared to the placebo group.Systematic Review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024517877.

5 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHaoyu Sun
Haoyu Sun
HDHan Deng
Han Deng
YLYixi Liu
Yixi Liu
ZHZitian He
Zitian He
GLGongyue Liu
Gongyue Liu
XLXing Li
Xing Li
This study aimed to investigate common complications during the chronic phase of spinal cord injury (SCI) and to assess bladder management methods and their associated complications in patients with neurogenic lower urinary tract dysfunction (NLUTD). A retrospective analysis was performed using clinical data from chronic-phase SCI patients across multiple centers in China. The study population included individuals diagnosed with SCI and admitted between January 1, 2017, and December 31, 2022. Chi-square tests were used to evaluate differences in the distribution of complications, disease duration, bladder management methods, and urinary complications. Univariate and multivariate analyses were conducted to identify risk factors for urinary complications. A total of 849 SCI patients from 28 provinces in China were included, showing significant demographic and clinical differences between traumatic SCI (TSCI) and non-traumatic SCI (NTSCI). Urinary tract infection (59.95%) and bowel-related complications, such as constipation (62.17%), were the most frequently reported complications. Additionally, the incidences of osteoporosis (38.50%), neuropathic pain (29.99%), bowel incontinence (12.06%), and hydronephrosis (11.91%) were also high. NLUTD was present in 90.58% of SCI patients. Among these, intermittent catheterization was associated with significantly lower rates of urological complications compared to indwelling catheterization (p = 0.025). Multivariate analysis identified bladder management method as a significant risk factor for urinary complications, with indwelling catheterization associated with a higher risk of urinary stones (p < 0.001) compared to intermittent catheterization. The high prevalence of bowel- and urological-related complications among Chinese SCI patients highlights the need for increased societal attention. In terms of bladder management, intermittent catheterization may provide greater benefits compared to indwelling catheterization. Further research and education are necessary to promote intermittent catheterization as a standardized bladder management approach for SCI patients.

25 October 2025 in European Urology Open Science
Verified
Journal Article
Open access
ZZZhonghan Zhou
Zhonghan Zhou
GLGongyue Liu
Gongyue Liu
JJJunjie Ji
Junjie Ji
YLYixi Liu
Yixi Liu
LLLimin Liao
Limin Liao
This study explores the associations of sarcopenia, obesity, and their coexistence (sarcopenic obesity) with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Data from the China Health and Retirement Longitudinal Study (CHARLS) 2011 and 2015 were analyzed. Participants aged ≥45 yr were categorized into four groups: normal, sarcopenia, obesity (defined as body mass index >25 kg/m2), and sarcopenic obesity. LUTS/BPH was assessed according to each patient’s medical history. Logistic regression was used to evaluate the association of obesity, sarcopenia, and sarcopenic obesity with BPH/LUTS. Interaction effects were further assessed to investigate the combined impact of sarcopenia and obesity. Among 6236 participants, 17% of those in the sarcopenic obesity group had BPH/LUTS, which is a significantly higher rate than in the other groups. Unadjusted logistic regression analysis showed that obesity (odds ratio [OR] 1.32, 95% confidence interval [CI] 1.10–1.58; p = 0.003) and sarcopenia (OR 1.19, 95% CI 1.06–1.35; p = 0.004) were associated with higher risk of LUTS/BPH. However, after adjusting for other biomarkers, only coexisting sarcopenia and obesity (OR 1.51, 95% 1.01–2.27; p = 0.046) was associated with significantly higher risk of LUTS/BPH, while no association was observed for either sarcopenia alone (OR 0.88, 95% CI 0.67–1.15; p = 0.3) or obesity alone (OR 0.99, 95% CI 0.72–1.35; p = 0.9). Sensitivity analyses confirmed these findings. The interaction between sarcopenia and obesity was significant, with 40% (95% CI 13–56%) of the risk attributed to their combined effect. Sarcopenic obesity was independently associated with higher risk of BPH/LUTS among older men in our cohort. Our study highlights the synergistic interaction between sarcopenia and obesity, and suggests a need for comprehensive management of both conditions to reduce the risk of BPH/LUTS. We looked at associations between a condition called sarcopenic obesity (obesity and a loss of muscle mass) and benign enlargement of the prostate gland causing urinary problems (called BPH/LUTS for short). We found that sarcopenic obesity is associated with a higher risk of BPH/LUTS in older men.

8 August 2025 in International Journal of Surgery
Verified
Journal Article
Open access
XWXuesheng Wang
Xuesheng Wang
FZFan Zhang
Fan Zhang
ZZZhonghan Zhou
Zhonghan Zhou
QFQiang Fu
Qiang Fu
LLLimin Liao
Limin Liao
Background: Bladder augmentation with gastrointestinal segments is a widely used surgical procedure for neurogenic bladder, but it carries a risk of many side effects. However, there have been no systematic studies on which biomaterials are suitable for bladder augmentation and reconstruction. The aim of this study was to compare the safety and applicability of small intestinal submucosa (SIS), poly(l-lactic) acid (PLLA) nanofibrous scaffold, and PLLA/gelatin composite nanofibrous scaffold as a potential bladder wall substitute material in tissue-engineered bladder augmentation and reconstruction. The results provide a scientific basis for selecting appropriate materials in clinical applications. Materials and Methods: The microstructure, cytocompatibility, cell adhesion, and histocompatibility of scaffolds including SIS, PLLA nanofiber scaffold, and PLLA/Gelatin were observed. Furthermore, bladder augmentation rabbit models were constructed using scaffolds with and without adipose-derived stem cells (ASCs) implantation. Cystography and urodynamic examination were performed to evaluate the morphology and function of the reconstructed bladder. Histologic and immunofluorescence were used to assess the regeneration status of the reconstructed bladder. Results: Compared to SIS and PLLA/Gelatin scaffolds, the PLLA scaffold possessed appropriate mechanical properties, pore size and porosity, which could facilitate suturing, maintain bladder form, and promote the adhesion and proliferation of seeded ASCs. All animals survived in the experiment with no complications, and the structural integrity of the implantation site was demonstrated using cystography and urodynamics. Histological and immunohistochemical analyses indicated that the three kinds of scaffold could regenerate the bladder wall structure at 6 and 12 weeks. Bladder reconstructed with the ASCs-PLLA scaffold showed superior structural and functional properties, with no significant differences in the regenerated urothelium, smooth muscle, or vessels of the ASCs-PLLA and control groups. Conclusion: The ASCs-PLLA scaffold – composed of PLLA with favorable biological properties and ASCs with facilitating regeneration – presents a promising candidate as an ideal scaffold for bladder augmentation and reconstruction.

29 August 2025 in International Journal of Surgery
Verified
Journal Article
Open access
XLXin Liu
Xin Liu
PZPing Zhong
Ping Zhong
TXTianyu Xiang
Tianyu Xiang
LLLimin Liao
Limin Liao
Background: The diagnosis of neurogenic lower urinary tract dysfunction (NLUTD) is complicated and often misdiagnosed by inexperienced physicians. Therefore, we used deep-learning algorithm models combined with video urodynamics to aid in the diagnosis of male NLUTD patients and construct an automated diagnosis and treatment process for such patients. Methods: The urodynamic data from two cohorts of patients in our center with NLUTD were used: (1) a total of 284 male patients with NLUTD from 2009 to 2019 were used for model training and validation optimization; and (2) a cohort of 100 male patients with NLUTD from 2020 to 2021 were used for model testing. The deep-learning algorithm models were yolov5 and yolov10. Based on pressure-flow traces and cystourethrography images, the qualitative and localization evaluation model of male NLUTD was constructed. Results: For the qualitative assessment of bladder outlet obstruction and detrusor contractility in male NLUTD patients, the best model was yolov10x, and the average precision (mAP) value of all categories was 0.89. For the localization evaluation of bladder outlet obstruction, the best model was yolov5x, and the average mAP value of all categories was 0.83. Conclusions: The yolov10x model can be used for qualitative evaluation of bladder outlet obstruction and detrusor contractility, and the yolov5x model can be used for localization evaluation of bladder outlet obstruction in male NLUTD patients.

9 December 2025 in International Journal of Surgery
Verified
Journal Article
Open access
ZZZhonghan Zhou
Zhonghan Zhou
GLGongyue Liu
Gongyue Liu
THTianyang Hang
Tianyang Hang
HJHuafang Jing
Huafang Jing
FZFan Zhang
Fan Zhang
LLLimin Liao
Limin Liao
Background: This preliminary study explores the potential of wearable single-channel electroencephalography (EEG) as a non-invasive biomarker for identifying urinary urgency and voiding intention, supported by the development of a lightweight, real-time processing algorithm. Materials and methods: A total of 20 individuals were recruited, and the EEG signals were recorded using a single-channel electrode placed on the frontal cortex. A lightweight convolutional neural network architecture based on a modified DenseNet was proposed, with only 75 194 trainable parameters. The performance was evaluated based on accuracy, precision, recall, and F1-score. Results: The lightweight proposed model achieved an accuracy of 0.8457, precision of 0.8540, recall of 0.9100, and F1-score of 0.8811 in classifying EEG signals for urgency. A 20-second epoch length was found optimal, balancing temporal richness and sample availability. Simple artifact detection methods, particularly slope thresholding, significantly improved performance. Compared with other lightweight architectures, the proposed model demonstrated superior accuracy and efficiency, making it well-suited for real-time and embedded EEG applications. Conclusion: This study demonstrates the feasibility of using wearable single-channel EEG as a non-invasive biomarker for detecting urinary urgency and voiding intention. These findings may facilitate the development of personalized and adaptive intelligent rehabilitation systems for managing lower urinary tract dysfunctions.